Company News
June 09 Positive feedback for Tournistrip from a large scale evaluation in the north of England
Tournistrip, the only tourniquet to have been clinically trialed
78% of phlebotomists actually preferred Tournistrip to their current tourniquet
A high proportion of conventional tourniquets are contaminated with blood and bacterial pathogens
The average reusable Tourniquet is owned for 1.86 years
Tournistrip's unique design and construction mean that it is truly single use